2nd Half of 2021 Stock Market Outlook

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – The stock market (SPY) has continued on a bullish path to start 2021. Yet it is not quite the same glorious bull run we enjoyed from the lows of last year. This market has become more volatile and with less upside potential. However, there is still plenty of money to be made if you look in the right places. That is the very nature of the new presentation I put together. So read on for more info….

I just wanted to share with you my brand new presentation:

2nd Half of 2021 Stock Market Outlook

The title is pretty self-explanatory. So as we are approach the mid-point of the year it is the right time to contemplate what lies ahead for the second half.

First, I start by exploring the bullish arguments. Gladly there are many when you consider the improving economic picture which begets higher corporate earnings. This has always been the main elixir for share price gains.

Interestingly there are two other catalyst at play that should have the market moving higher this year. Unfortunately one of them has a fairly negative slant that leads to greater volatility (maybe you already noticed that at play).

Next we need to flip the script and contemplate the bearish arguments. Gladly there is not much in this category. However, the flickering flames of inflation are a concern we need to keep a close eye on as it has been the precursor to many bear markets of the past.

After balancing out the bullish and bearish arguments I then go on to give a year end target for the S&P 500. Yes, it is higher than now, but not significantly higher. That’s because the easy money has already been made leading to slower gains ahead.

As we come down the home stretch of the webinar I discuss strategies to outperform the market. And my top 12 stocks and 2 ETFs that have the right stuff to excel the rest of the year.

To get full details on the market outlook, trading plan and top picks, then click the link below to watch the presentation now:

2nd Half of 2021 Stock Market Outlook

Steve Reitmeister
…but everyone calls me Reity (pronounced “Righty”)
CEO, StockNews & Editor of Reitmeister Total Return


SPY shares . Year-to-date, SPY has gained 13.86%, versus a % rise in the benchmark S&P 500 index during the same period.


About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating
.INXGet RatingGet RatingGet Rating
DIAGet RatingGet RatingGet Rating
IWMGet RatingGet RatingGet Rating
QQQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Investor Alert: Keep Calm and Carry On

The stock market (SPY) took a scary turn on Monday as news of Evergrande culminated in a worldwide sell off. Now with a little time and perspective investors see this was more smoke than actual fire creating a buy the dip event. Why did this happen? And where do stocks head next? Read on for those answers and more below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News